2021 Investor Day

Disciplined and strategic M&A approach Strategic intent GU Portfolio enhancement Geographic expansion Added capabilities and technology Market development Financial criteria Enhances revenue profile Attractive operating margin © 2021 ResMed | 2021 Investor Day – Sept 8, 2021 Strengthen competitive position EPS accretion (typically, within 2 years) ROIC > WACC (within designated timeframe) 85

View entire presentation